Skip to main content

EXPLORE CASE STUDIES IN BULLOUS PEMPHIGOID

Review the pictures of patients with bullous pemphigoid below and consider who may be appropriate for DUPIXENT.

Diagnosing bullous pemphigoid

Thorough clinical examination and laboratory investigations are necessary, as outlined by EADV guidelines1,a

Patient history

  • Date of onset
  • Signs and symptoms, including itch, and how they have
    changed over time
  • Comorbidities potentially associated with bullous pemphigoid
  • Detailed drug history (within 6 months of symptom onset)

Patient assessment

  • Daily blister count or Bullous Pemphigoid Disease Area Index

Physical examination

  • Bullous presentations
    • Severely pruritic, with bullae and/or erosions on erythematous, inflamed skin
  • Non-bullous presentations, including:
    • Eczematous and urticarial lesions
    • Prurigo nodularis-like lesions
    • Pruritus with or without skin lesions
  • Direct immunofluorescence (DIF)
  • Histopathology
  • Enzyme-linked immunosorbent assay (ELISA)
  • Indirect immunofluorescence (IIF)

Other immunopathological tests1:

  • Immunoblotting and novel ELISAs
  • Fluorescence overlay antigen mapping (FOAM)
  • Immunochemistry

aEuropean Academy of Dermatology and Venereology (EADV) guidelines for the management of bullous pemphigoid.